MDA Ltd.
MDALF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.70 | -2.15 | 0.90 | -2.24 |
| FCF Yield | -0.85% | -0.39% | 6.06% | 8.73% |
| EV / EBITDA | 88.72 | 63.02 | 41.73 | 50.78 |
| Quality | ||||
| ROIC | 1.04% | 1.74% | 1.64% | 1.54% |
| Gross Margin | 19.01% | 25.40% | 22.71% | 23.63% |
| Cash Conversion Ratio | 0.97 | 1.94 | 8.12 | 15.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.07% | 21.42% | 19.58% | 18.98% |
| Free Cash Flow Growth | -115.88% | -108.28% | -34.78% | 53.26% |
| Safety | ||||
| Net Debt / EBITDA | 3.33 | -4.27 | -3.15 | -0.42 |
| Interest Coverage | 2.88 | 15.03 | 7.20 | 3.54 |
| Efficiency | ||||
| Inventory Turnover | 13.62 | 20.48 | 21.88 | 32.68 |
| Cash Conversion Cycle | 19.06 | -6.38 | -2.07 | 16.87 |